194 related articles for article (PubMed ID: 37328748)
1. Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection.
Qi H; Dong D; Liu N; Xu Y; Qi M; Gu Q
BMC Infect Dis; 2023 Jun; 23(1):409. PubMed ID: 37328748
[TBL] [Abstract][Full Text] [Related]
2. Caspofungin combined with TMP/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection.
Tian Q; Si J; Jiang F; Xu R; Wei B; Huang B; Li Q; Jiang Z; Zhao T
HIV Med; 2021 Apr; 22(4):307-313. PubMed ID: 33277811
[TBL] [Abstract][Full Text] [Related]
3. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
[TBL] [Abstract][Full Text] [Related]
4. A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
Li H; Lu Y; Tian G; Wu Y; Chen T; Zhang J; Hu N; Wang X; Wang Y; Gao L; Yan J; Zhou L; Shi Q
BMC Infect Dis; 2024 Jan; 24(1):152. PubMed ID: 38297200
[TBL] [Abstract][Full Text] [Related]
5. No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study.
Huang Y; He X; Chen H; Harypursat V; Lu Y; Yuan J; Nie J; Liu M; Yu J; Zhang Y; Jiang Z; Qin Y; Xu L; Zhou G; Zhang D; Chen X; Zheng B; Chen Y
Infect Dis Ther; 2022 Feb; 11(1):543-557. PubMed ID: 35050490
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of trimethoprim-sulfamethoxazole for the prevention of pneumocystis pneumonia in human immunodeficiency virus-negative immunodeficient patients: A systematic review and meta-analysis.
Li R; Tang Z; Liu F; Yang M
PLoS One; 2021; 16(3):e0248524. PubMed ID: 33765022
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first-line therapy to treat non-HIV patients with severe pneumocystis pneumonia.
Zhang G; Chen M; Zhang S; Zhou H; Ji X; Cai J; Lou T; Cui W; Zhang N
Exp Ther Med; 2018 Feb; 15(2):1594-1601. PubMed ID: 29399131
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of caspofungin, a 1,3-β-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats.
Sun P; Tong Z
Med Mycol; 2014 Nov; 52(8):798-803. PubMed ID: 25288652
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice.
Lobo ML; Esteves F; de Sousa B; Cardoso F; Cushion MT; Antunes F; Matos O
PLoS One; 2013; 8(8):e70619. PubMed ID: 23940606
[TBL] [Abstract][Full Text] [Related]
10. Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim/sulfamethoxazole.
Chen PY; Yu CJ; Chien JY; Hsueh PR
Int J Antimicrob Agents; 2020 Jan; 55(1):105820. PubMed ID: 31622654
[TBL] [Abstract][Full Text] [Related]
11. A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.
Kosaka M; Ushiki A; Ikuyama Y; Hirai K; Matsuo A; Hachiya T; Hanaoka M
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893787
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure.
Liu A; Sun R; Cao G; Liu X; Zhu H; Yang J
BMC Infect Dis; 2022 Jun; 22(1):546. PubMed ID: 35701759
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia.
Guo J; Chen Z; Kong C; Yu B; Wang T; Zhang Y; Liu Y; Zhou J; Qiu T
J Chemother; 2023 May; 35(3):181-187. PubMed ID: 35815561
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review.
Li H; Huang H; He H
BMC Pulm Med; 2016 Nov; 16(1):144. PubMed ID: 27835947
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
[TBL] [Abstract][Full Text] [Related]
16. Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation.
Lu YM; Lee YT; Chang HC; Yang HS; Chang CY; Huang CM; Wei J
Transplant Proc; 2017 Oct; 49(8):1893-1898. PubMed ID: 28923644
[TBL] [Abstract][Full Text] [Related]
17. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
[TBL] [Abstract][Full Text] [Related]
18. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
19. A Pilot Study of Echinocandin Combination with Trimethoprim/Sulfamethoxazole and Clindamycin for the Treatment of AIDS Patients with Pneumocystis Pneumonia.
Wang M; Lang G; Chen Y; Hu C; Guo Y; Tao R; Dong X; Zhu B
J Immunol Res; 2019; 2019():8105075. PubMed ID: 31886310
[TBL] [Abstract][Full Text] [Related]
20. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
